Xenical (ZEN-I-cal, orlistat), a new prescription drug for obesity

June 1997

The FDA will soon approve Xenical (ZEN-i-cal, orlistat), a new prescription drug for obesity from Roche.

Xenical ISN'T an appetite suppressant.

It's a pancreatic lipase inhibitor. It works in the intestine to reduce the absorption of fat by about 30%.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

New ways to control drug costs
Cardiology Coreg (carvedilol) is the first beta blocker approved for congestive heart failure
Renal & Urology Adverse sexual effects from SSRI antidepressants are more common
Renal & Urology New once-a-day drug for benign prostatic hyperplasia, Flomax (tamsulosin)
Pregnenolone is the latest hormone to grab the public's attention
Lots of new interest in the omega-3 fatty acids
Flaxseed is becoming very popular
Obesity & Weight Loss Xenical (ZEN-I-cal, orlistat), a new prescription drug for obesity
Obesity & Weight Loss Actigall (ursodiol) is now approved to PREVENT gallstones
A new machine to measure cholesterol levels while patients are in your office
Smoking Cessation Zyban hits pharmacies next month it'll be the first non-nicotine drug approved for smoking cessation
Smoking Cessation New Nicotrol INHALER for smoking cessation
Gastroenterology Nicotine for ulcerative colitis
STIs New treatments for external genital and perianal warts
Denied an application for a generic Premarin
Practice New guidelines for preventing bacterial endocarditis